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TO THE EDITOR
Recent years have seen considerable
advances in understanding the molecu-
lar basis of autosomal-recessive forms of
congenital ichthyosis. Indeed, mutations
in seven different genes and a further
two loci have been implicated. These
comprise TGM1 on 14q11.2 (Huber
et al., 1995), ALOX12B and ALOXE-3
on 17p13.1 (Jobard et al., 2002),
ABCA12 on 2q34 (Lefevre et al., 2003),
Ichthyin on 5q33 (Lefevre et al.,
2004), CGI-58 on 3p21 (Lefevre et al.,
2001), FLJ39501 on 19p12 (Lefevre
et al., 2006), and undisclosed genes on
12p11.2–q13 (Mizrachi-Koren et al.,
2005) and 19p13.1–p13.2 (Virolainen
et al., 2000). Nevertheless, cases of
autosomal-recessive congenital ichthyo-
sis display considerable clinical diversity
and some phenotypes may be striking
and unusual, perhaps indicating further
genetic heterogeneity. One such form of
autosomal-recessive congenital ichthyo-
sis is ‘‘badpak’’ or bathing suit ichthyosis
(BSI), a disorder that is found in parts of
South Africa. This condition was first
reported in the 1970s (Scott, 1972; Scott
and Lups, 1974) and further clinico-
pathological details have been published
recently (Jacyk, 2005). In brief, the
characteristic features consist of auto-
somal-recessive inheritance, skin ab-
normalities at birth (mainly collodion
babies), and large dark grey/brownish
scales affecting the trunk and scalp but
sparing the central face, buttocks, and
limbs. Palms and soles are dry and
diffusely mildly hyperkeratotic. The dor-
sal aspects of the hands and feet appear
normal and there are no nail abnormal-
ities. The main feature is the truncal
distribution of the ichthyosis which has
led to the colloquial term ‘‘bathing suit’’.
BSI may not be a uniquely South African
genodermatosis, but it has a remarkably
consistent phenotype within this popula-
tion (Scott, 1972; Scott and Lups, 1974;
Jacyk, 2005). Skin biopsies have shown
orthohyperkeratosis and acanthosis but
no discriminating findings (Jacyk, 2005).Abbreviation: BSI, bathing suit ichthyosis; SNP, single-nucleotide polymorphism
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The aim of this study, therefore, was to
determine the molecular basis of this
disorder. The fact that BSI only occurs in
South Africa and that propagation of an
ancestral mutant allele has been sus-
pected led us to perform homozygosity
mapping using a single-nucleotide poly-
morphism (SNP) chip approach.
Following Ethical Committee ap-
proval and in compliance with the
Declaration of Helsinki Principles, and
after obtaining informed consent from
all subjects, genomic DNA from eight
affected individuals was examined.
Those studied were all South African
blacks seen in the Department of
Dermatology, University of Pretoria,
five of which were included in the
series recently published by Jacyk
(2005). The group consists of
three male and five female individuals,
aged between 7 and 27 years. The
qmain clinical features are illustrated
qin Figure 1. Additional details have
been described elsewhere (Jacyk,
2005).
To identify the BSI gene, all eight
DNA samples were SNP-genotyped
using an SNP GeneChip mapping 10 K
assay according to the manufacturer’s
instructions (Affymetrix, High Wycombe,
UK). Each microarray was scanned using
the GeneChips scanner 3000 and
GeneChips Operating software (GCOS)
v1.1.1 with patch 5. The data were
analyzed using GeneChips DNA Ana-
lysis Software (GDAS) v3.0. Briefly,
250 ng of genomic DNA was digested
with XbaI. Adaptor Xba was ligated to
the digested DNA and these samples
were amplified by PCR with Xba pri-
mers. PCR products were fragmented by
DNaseI and labeled with biotin. The
labeled DNA fragments were then hy-
bridized to the SNP array. Hybridized
arrays were processed with an Affyme-
trix Gene Chip Fluidics Station 450, and
fluorescence signals were detected using
the Affymetrix GeneChip Scanner 3000.
Raw SNP call data were extracted using
GeneChip Genotyping Analysis Software
and imported into Microsoft Excel for
analysis. The average call rate (expressed
as a percentage) 7SEM for the eight
patients was 80.872.3%.
From the SNP assay analysis, seven
regions of the genome were found
to have large blocks of homozygosity
for all affected individuals. Of note,
these included a 1.2 Mb interval
(22757380–23916597) on chromosome
14q11, which contains the TGM1 gene.
The patients’ genomic DNA was there-
fore amplified with primers specific for
TGM1, as described elsewhere (Laiho
et al., 1997), and the PCR products
a b c
Figure 1. Clinical features of individuals with BSI. Coarse brown/black skin scaling is restricted
to (a) trunk and (b) scalp, sparing the face, (c) buttocks, and extremities.
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Figure 2. DNA sequencing demonstrates that BSI is due to a homozygous missense mutation in TGM1
and is therefore allelic to lamellar ichthyosis. (a) Sequencing reveals a homozygous single-nucleotide
transversion in TGM1 (NM_000359 c.944G4T) in the affected individuals which converts an arginine
residue (CGT) to leucine (CTT), designated p.R315L. (b) Illustration of all previously reported mutations in
TGM1 within the postulated sub-domains of the transglutaminase 1 protein (Candi et al., 2005). The
resultant clinical phenotypes are indicated by different colors: black, lamellar ichthyosis; blue,
non-bullous congenital ichthyosiform erythroderma; green, both lamellar ichthyosis and non-bullous
congenital ichthyosiform erythroderma; red, the mutation defined in BSI, although a case of classical
lamellar ichthyosis with this mutation has also been reported (ref. Tok et al., 1999). *Self-healing
collodion baby as well as lamellar ichthyosis has been reported for this mutation (Raghunath et al.,
2003). **A case of lamellar ichthyosis sparing the face and extremities, with some clinical similarities
to BSI, has been reported for this mutation (Petit et al., 1997). ***Self-healing collodion baby
with no residual scaling has been reported for this mutation (Raghunath et al., 2003). One further
unrepresented mutation in the promoter region (86C4T) has been reported in a case of lamellar
ichthyosis (Cserhalmi-Friedman et al., 2001).
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were sequenced by means of ABI
BigDye Terminator reagents (Applied
Biosystems, Warrington, UK) in an ABI
310 sequencer.
Sequencing disclosed a homozygous
G4T transversion at nucleotide
c.944 (GenBank No. NM_000359) in
exon 6 of TGM1 (Figure 2a). This
mutation converts an arginine residue
to leucine and is designated p.R315L.
This mutation was found in all eight
DNA samples and is likely to represent
a founder effect in this population.
Indeed, several of the affected indivi-
duals belong to the Nguni ethnic groups
(Zulu, Swazi, and Xhosa). No other
sequence variations were identified in
the coding or splice site regions. The
p.R315L substitution was not identified
as a polymorphism by screening 50
ethnically matched control genomic
DNA samples.
This molecular analysis indicates
that BSI is a particular form of lamellar
ichthyosis caused by a homozygous
missense mutation, p.R315L, in
the TGM1 gene which encodes trans-
glutaminase 1. This enzyme has a
vital role in the formation of the
cornified cell envelope by crosslinking
several precursor proteins (such
as involucrin) and in crosslinking hy-
droxyceramide to the cornified cell
envelope (Candi et al., 2005). Loss
or reduction of its activity leads to
defective cornified cell envelope
formation and collapse of the stratum
corneum lipid barrier. More than
40 different TGM1 mutations
have now been identified (see Figure
2b). These have been associated with
various autosomal-recessive forms of
congenital ichthyosis phenotypes
usually called lamellar ichthyosis or
non-bullous congenital ichthyosiform
erythroderma. In some reports, how-
ever, other forms of ichthyosis have also
been ascribed to TGM1 mutations
(Raghunath et al., 2003).
The mutated arginine we identified
in the BSI individuals is likely to be
pathogenic as it is located within the
core domain of transglutaminase 1, a
site involved in stabilizing the structural
conformation of the enzyme through
salt bridge and hydrogen bonds linked
to neighboring amino acids (Huber
et al., 1997). Furthermore, arginine
315 is highly conserved throughout
the transglutaminase family. Remark-
ably, the p.R315L mutation in TGM1
has been previously reported in
African-American twins with a more
classical phenotype of lamellar ichthyo-
sis (Tok et al., 1999). In those
cases, skin scaling was very extensive,
sparing only the face and the flexures,
and did not show a ‘‘bathing suit’’
distribution.
How can the unusual and striking,
patchy but consistent, skin involvement
in BSI be explained? The pattern of
involvement is not in keeping with any
particular segmental distribution or
form of mosaicism – it is clearly a fully
penetrant autosomal-recessive disorder
with minimal inter- and intra-familial
variability. It appears to be a distinct
clinical disorder, although one case of
lamellar ichthyosis sparing the face and
the four limbs, with some similarities to
BSI, has been reported (Petit et al.,
1997). Indeed, the presence of involved
and uninvolved skin with varying
clinical presentations in several other
cases of autosomal-recessive congenital
ichthyosis is well recognized but poorly
understood because of limited insight
from genotype–phenotype correlation
studies (Akiyama, 2006). A comparative
study of involved and uninvolved
skin in lamellar ichthyosis resulting
from TGM1 mutations showed reduced
TGM1 activity in both affected and
unaffected skin but more so in
the affected regions (Petit et al., 1997).
The sparing of the extremities and
face in BSI suggests that the p.R315L
mutation may not abolish the activity
of transglutaminase 1 completely,
but this does not explain the peculiar
scaling pattern seen in all cases
of BSI.
In summary, we have determined
that the South African bathing suit form
of ichthyosis is a variant of lamellar
ichthyosis associated with TGM1 gene
pathology. Delineation of a specific
mutation in the form of p.R315L has
important implications for the affected
population in South Africa. We esti-
mate that there are at least 50 affected
families within the Pretoria and Johan-
nesburg districts, and therefore knowl-
edge of the molecular basis of BSI will
be very helpful in improving genetic
counseling within this South African
population.
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TO THE EDITOR
Xeroderma pigmentosum (XP) is an
inherited human disorder in which
patients have greatly elevated inci-
dence of solar-induced cancers caused
by mutations in genes for nucleotide
excision repair or polymerase Z that are
required for repair or replication of
damaged DNA (Hoeijmakers, 2001;
Wood et al., 2001; Cleaver and Mitchell,
2006). We report a cluster of XP-C
patients within an isolated Guatemala
community containing a new mutation.
A recently diagnosed US XP-C patient
was also analyzed for comparison and
found to be a compound heterozygote
for two novel mutations in the XPC
gene.
A Guatemala village containing
many XP patients was identified by
missionaries from Good Samaritans
International, in consultation with phy-
sicians in Guatemala City. Among a
total of about 50 children, approxi-
mately 12 had evidence of photosensi-
tivity, severe poikloderma, and multiple
non-melanoma skin cancers. Their tu-
mors were often advanced, showing
necrosis and infection and the children
suffered continual pain from sun ex-
posure. There was no evidence of
neurological symptoms seen in the XP
patients identified, such as hearing loss
and ataxia (Cleaver and Mitchell,
2006). However, the majority of the
affected children do not live beyond
their 10th birthday and later findings of
neurological degeneration would not
be identified. There were no reported
skin cancers among parents. According
to oral tradition, the village originated
in a common family approximately 100
years ago. Intermarriage is high and we
hypothesized that the XP patients
would be homozygous for the same
mutation in an XP gene (see Table 1).
Blood samples were obtained from a
male patient (XP202BA), his father
(XP211BA), and one other father
(XP212BA) of an XP patient who was
not directly related. Blood samples
were also obtained from a newly
diagnosed US patient seen at the Uni-
versity of California San Francisco
(UCSF) (XP207SF). This patient was a
2-year-old female born of non-consan-
guineous parents who had extensive
facial freckling and a small squamous
cell carcinoma on the bridge of the
nose that was biopsied for diagnosis.
The purpose of the sample collection
was carefully explained to donors and
parents under the terms of a current
UCSF Committee on Human Research
permit and the Declaration of Helsinki
Principles. Parents of subjects con-
sented to blood draws in Guatemala
via translators in the presence of the
local health official and documentation
was retained by their physicians. Lym-
phocytes were transformed by Epstein–-
Barr virus infection and permanent
lymphoblastoid cell lines were estab-
lished and given UCSF designations. A
previously classified XP-C lymphoid
cell line (GM02498) was obtained from
the Coriell Cell Repository (Camden,
NJ) and a normal cell line (PPO34)
from a UCSF bank. Fibroblast cultures
were obtained from the UCSF patient
and for GM02498 (GM00676 orAbbreviation: CSF, University of California San Franciso; XP, xeroderma pigmentosum.
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